What travelers should know
On 16 October 2026, the U.S. Centers for Disease Control and Prevention issued a Level 2 (Practice Enhanced Precautions) travel health notice for an outbreak of yellow fever in the Upper West Region of Ghana.
Yellow fever is a viral illness spread by the bite of infected Aedes and Haemagogus mosquitoes, which in urban areas commonly bite during daylight hours. Most infections cause mild or no symptoms, but a minority of cases progress to severe disease with jaundice, bleeding, and organ failure. There is no specific antiviral therapy; care is supportive, which is why prevention through vaccination and bite avoidance is the public health priority.
CDC's published recommendations
- Travelers going to the Upper West Region should be vaccinated against yellow fever at least 10 days before travel, the interval after which protective immunity is generally considered established.
- Take steps to prevent mosquito bites throughout the trip, including EPA-registered insect repellents, long sleeves and trousers, permethrin-treated clothing or gear, and air-conditioned or screened accommodation.
- Seek medical care promptly for fever or other illness during or after travel, and mention the travel history to the clinician.
Entry requirements and documentation
Ghana requires proof of yellow fever vaccination for entry for most travelers. Vaccination is documented on an International Certificate of Vaccination or Prophylaxis (ICVP, "yellow card"), which is valid for life under current International Health Regulations. Travelers should confirm current entry rules with the destination's official sources and keep the certificate with their passport, as onward countries may also request it.
Pharmacist commentary
Yellow fever vaccine is a live attenuated product administered only at designated vaccination centers in many countries, so appointments may need to be booked weeks in advance. Certain groups — including infants, older adults, pregnant or breastfeeding travelers, and people who are immunocompromised, have thymus disorders, or have egg or gelatin allergies — require individualized risk–benefit assessment, and a medical waiver letter is sometimes issued instead of vaccination. Timing relative to other live vaccines also matters.
Pharmacist's note: This summary is general public-health information, not medical advice, and no treatment or dosing guidance is given here. Eligibility, contraindications, vaccine timing, waiver documentation, and repellent selection should be assessed individually by a travel medicine clinician, physician, or pharmacist authorized to vaccinate — ideally 4–6 weeks before departure. Bring a full list of your current medications and your immunization records to that visit, and verify requirements against CDC and destination government sources before you fly.